118 related articles for article (PubMed ID: 2423783)
21. Hemodynamic effects of alpha1-adrenoceptor antagonist, doxazosin, in patients with chronic congestive heart failure.
Kieback AG; Rödiger O; Jaenecke H; Grohmann A; Wernecke KD; Baumann G; Felix SB
J Cardiovasc Pharmacol; 2005 Oct; 46(4):399-404. PubMed ID: 16160589
[TBL] [Abstract][Full Text] [Related]
22. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
Leier CV; Huss P; Magorien RD; Unverferth DV
Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
[TBL] [Abstract][Full Text] [Related]
23. Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure.
Ryman KS; Kubo SH; Lystash J; Stone G; Cody RJ
Am J Cardiol; 1986 Sep; 58(7):583-8. PubMed ID: 3751928
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Marshall AJ; Kettle MA; Barritt DW
Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
[TBL] [Abstract][Full Text] [Related]
25. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
26. Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Melenovsky V; Koepp KE
Circ Res; 2016 Sep; 119(7):880-6. PubMed ID: 27458234
[TBL] [Abstract][Full Text] [Related]
27. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
Rubin SA; Tabak L
J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
[TBL] [Abstract][Full Text] [Related]
28. Alpha-adrenoreceptor blockade with indoramin in hypertension.
Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
[TBL] [Abstract][Full Text] [Related]
29. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
Luomanmäki K; Hartikainen M
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
[TBL] [Abstract][Full Text] [Related]
30. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
[TBL] [Abstract][Full Text] [Related]
32. Effect of indoramin on finger circulation in patients with Raynaud disease.
Clement DL; Duprez D; De Pue N
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S84-7. PubMed ID: 2423806
[TBL] [Abstract][Full Text] [Related]
33. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
[TBL] [Abstract][Full Text] [Related]
34. Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure.
Quyyumi AA; Wagstaff D; Evans TR
Am J Cardiol; 1984 Nov; 54(8):1020-4. PubMed ID: 6496323
[TBL] [Abstract][Full Text] [Related]
35. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic action of nicorandil in chronic congestive heart failure.
Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.
McGrath BP; Newman R; Older P
Am J Med; 1989 Apr; 86(4A):75-80. PubMed ID: 2523660
[TBL] [Abstract][Full Text] [Related]
38. Improvement in angina pectoris with alpha adrenoceptor blockade.
Collins P; Sheridan D
Br Heart J; 1985 May; 53(5):488-92. PubMed ID: 2859870
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of vasodilators and long-term response in heart failure.
Franciosa JA; Dunkman WB; Leddy CL
J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
[TBL] [Abstract][Full Text] [Related]
40. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]